Zurueck zur Suche

Reporte zur Charge NR55Z

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

17Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 3 CO 3 WI 2 MO 2 PA 1 IL 1 OR 1 IN 1 MI 1

VAERS 1365465

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

schwer
Staat
CA
Alter
71,0
Geschlecht
M
Eingang
01.06.2021
Impfdatum
30.05.2021
Beginn
31.05.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Asthenia Fall Fatigue Loss of consciousness

Symptomtext

Patient had a shingrix immunization on 5/30/2021. On the next morning at home (5/31/21), stated that he felt weak while in the kitchen, passed out and fell to the floor. The patient did not describe any injuries from the incident and said that he just felt weak and fatigued afterwards. Patient chose to rest the day. Patient does not have note of his blood pressure at the time and no medications on file to assess contributing factors. Today, he states he is feeling better. Advised to follow up with provider as well. Left message for patient to get information regarding provider as to notify primary regarding incident

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2521687

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

moderat
Staat
-
Alter
71,0
Geschlecht
M
Eingang
29.12.2021
Impfdatum
28.05.2021
Beginn
25.05.2021
Tage bis Beginn
-
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chest pain Headache

Symptomtext

Narrative: Patient received his second Shingrix vaccine on 5/28/21 and 2 to 3 hours later he had c/o a headache and chest pain that resolved without treatment. No documentation of any reactions when he received his first vaccine on 7/5/19.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1401651

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

moderat
Staat
PA
Alter
52,0
Geschlecht
F
Eingang
16.06.2021
Impfdatum
15.05.2021
Beginn
01.05.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Condition aggravated Psoriasis

Symptomtext

Used to have psoriasis / started with an break out all over her body(arms, back, legs); This case was reported by a pharmacist via call center representative and described the occurrence of psoriasis aggravated in a 53-year-old female patient who received Herpes zoster (Shingrix) (batch number NR55Z, expiry date 22nd October 2022) for prophylaxis. Concurrent medical conditions included psoriasis. On 15th May 2021, the patient received the 1st dose of Shingrix. In May 2021, 2 weeks after receiving Shingrix, the patient experienced psoriasis aggravated. On an unknown date, the outcome of the psoriasis aggravated was unknown. It was unknown if the reporter considered the psoriasis aggravated to be related to Shingrix. Additional details were provided as follows: The reporter was looking for information about Shingrix common side effects after 1st dose because the patient that used to have psoriasis received Shingrix 1st dose and two weeks later started with a breakout all over her body (arms, back, legs). The reporter consented to follow up by phone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Psoriasis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1351432

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

moderat
Staat
WI
Alter
67,0
Geschlecht
F
Eingang
26.05.2021
Impfdatum
24.05.2021
Beginn
25.05.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dehydration Dizziness Feeling abnormal Headache Pain

Symptomtext

4:30am woke up with a headache, aches. Took otc pain medication at that time. Went back to sleep and woke at 9:30am feeling off, very dizzy, and felt like veins were "flat." Attempted to call pt back today, but did not answer. Suggested may be a bit dehydrated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dehydration
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
paroxetine
Allergien
n/a
Vorherige Impfungen
-

VAERS 1873698

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

mild
Staat
IL
Alter
84,0
Geschlecht
F
Eingang
16.11.2021
Impfdatum
16.11.2021
Beginn
16.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Fatigue Gait inability Headache Vomiting

Symptomtext

She felt dizziness and was unable to walk within 15 mins of leaving. She went to a grocery store after leaving health department had to have two people walk her to her car. Sat in her car for an hour. Once she got home she was able to walk into the house. Has laid around all afternoon and has felt fatigue. Vomited yellowish bile once she got home. States she now at 3:10 pm, feels better but does feel tired with a headache.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
No
Vorgeschichte
Cholesterol, back pain, anxiety
Andere Medikamente
Omeprazole, Imodium, Buspirone, losartan, meloxicam, pravastatin, Tylenol, 81 mg aspirin, vit E, fish oil, garlic, cranberry supplements, niacin, multivitamin
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1501983

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

mild
Staat
CO
Alter
58,0
Geschlecht
F
Eingang
26.07.2021
Impfdatum
21.05.2021
Beginn
22.05.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Aphasia Chills Fatigue Headache Pyrexia Visual impairment

Symptomtext

Pt experienced usual SE initially - was very fatigued w/ fever of 101 for 1.5 x days, HA, chills - those then resolved. On 5/22 she began having word finding difficulty, difficulty processing, vision deficits and has overall regressed back to where she was in 7/20 (immediately after brain surgery). Pt feels that acutely worsened symptoms were due to recieving Shingrix vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
on medication for recurrent cancer- Osimertinib
Vorgeschichte
hx of small cell lung cancer, hx of metastatic brain cancer,
Andere Medikamente
Osimertinib, Bone Guard Forte, CBD, DHEA, estradiol, magnesium glycinate, progesterone, methylphenidate, NP thyroid, vit D, vit K2,
Allergien
sulfa
Vorherige Impfungen
-

VAERS 1487720

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

mild
Staat
OR
Alter
63,0
Geschlecht
F
Eingang
20.07.2021
Impfdatum
08.07.2021
Beginn
10.07.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Contusion Pain in extremity Peripheral swelling Rash

Symptomtext

patient developed a lot of pain in the arm, swelling and rash after administration, developed bruising in the area several days later

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
chronic pain, severe COPD, non healing thoracic compression fractures, osteoporosis
Andere Medikamente
linzess, methocarbamol, oxycodone, cetirizine, gabapentin, duloxetine, boniva, montelukast, lexapro, trelegy ellipta, prolia, oxygen,
Allergien
bee venom, pcn, codeine, amoxil, aspirin, augmentin, pollen, hydromorphone, cyclobenzaprine
Vorherige Impfungen
-

VAERS 1413487

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

mild
Staat
CO
Alter
62,0
Geschlecht
M
Eingang
20.06.2021
Impfdatum
18.06.2021
Beginn
20.06.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Infection Injection site erythema Injection site warmth Vaccine positive rechallenge

Symptomtext

This previously happened to patient when he got the first dose of Shingrix, including the same symptoms. He reported redness and heat on day 2 after receiving the vaccine. This occurred below the injection site. He went to urgent care and they reported that he had an infection and gave him keflex 500 mg.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
type 2 DM, rheomatoid arthritis,
Andere Medikamente
omeprazole 40 mg, lisinopril 10 mg, soma 250 mg, diltiazem 24H er(cd)240 mg, metformin 500 mg, butorphanol 10mg/ml, prednisone 5 mg, folic acid 1mo, methotrexate 2.5 mg
Allergien
carbamates, nsaids, meloxicam, naproxen, salicylates, sulfa, ephedrine, aspirin, sulfapyridine,
Vorherige Impfungen
Shingrix dose 1

VAERS 1371671

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

mild
Staat
IN
Alter
66,0
Geschlecht
F
Eingang
03.06.2021
Impfdatum
01.06.2021
Beginn
02.06.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Administration site swelling Administration site warmth Injection site erythema

Symptomtext

Patient had medium to large size elevated red spot at site of administration. The spot felt slightly warm to the touch and was elevated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1360738

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge nr55z

mild
Staat
MI
Alter
84,0
Geschlecht
F
Eingang
29.05.2021
Impfdatum
26.05.2021
Beginn
26.05.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Fatigue Pyrexia

Symptomtext

LIGHT FEVER (102), CHILLS, FATIGUE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none mentioned
Vorgeschichte
none mentioned
Andere Medikamente
finasteride
Allergien
Non mentioned
Vorherige Impfungen
-

VAERS 1337027

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

mild
Staat
MO
Alter
64,0
Geschlecht
F
Eingang
21.05.2021
Impfdatum
11.05.2021
Beginn
12.05.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site pain Injection site pruritus Injection site swelling Rash macular

Symptomtext

Patient called the clinic to report that she was given a SHINGRIX vaccine at the pharmacy on Tuesday 5/11/2021 after her clinic visit here with the doctor and developed swelling, pain that is a 6, red blotches below the injection site, tenderness, and itching. Doctor recommended the patient take Benadryl 25 mg, 1 tab now and Ibuprofen 200 mg, 3 tabs q 8 hours as needed for pain. If she develops more swelling, fever, chills to go to urgent care or ER (5/14/21). The reported symptoms were consistent with localized reaction to vaccine. Clinic nurse followed up with patient on 5/15/21. The patient stated the symptoms had already resolved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1323440

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

mild
Staat
CA
Alter
52,0
Geschlecht
M
Eingang
17.05.2021
Impfdatum
11.05.2021
Beginn
13.05.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cellulitis Hypersensitivity Infection Injection site erythema

Symptomtext

Localized redness about 6cm below site of injection. Likely mild allergic reaction to a product within either the MMR, Considered infection/cellulitis, but I think it is less likely at this time given location away from injection site. -advised continued use of Ibuprofen and tylenol. Advised to take Benadryl or Zyrtec. - return precautions given for worsening symptoms, to which patient gave understanding and agreement.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Type II diabetes w/o complication, without use of insulin, GERD, uric acid nephrolithiasis, diastasis recti, OSA Severe
Andere Medikamente
baclofen 10mg , metformin 1000mg, allopurinol 100mg, trazodone 50mg, potassium citrate CR 10mEq
Allergien
NKA
Vorherige Impfungen
-

VAERS 2576971

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

gering
Staat
-
Alter
60,0
Geschlecht
M
Eingang
04.11.2021
Impfdatum
07.07.2021
Beginn
07.07.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1678925

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

gering
Staat
WI
Alter
77,0
Geschlecht
U
Eingang
07.09.2021
Impfdatum
30.06.2021
Beginn
19.07.2021
Tage bis Beginn
19,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Herpes zoster

Symptomtext

After receiving vaccine, patient broke out in shingles as confirmed by his provider on 07/19/21/ A course of valacylovir 1gm, doing 1 tid was dispensed for a 7 day supply.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Herpes zoster
Hospital-Tage
-
Labordaten
Appointment on 07/19/21
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1440200

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

gering
Staat
CO
Alter
62,0
Geschlecht
F
Eingang
01.07.2021
Impfdatum
21.06.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

administered / shingrix on 6/21/2021 / was left outside at room temperature for a week; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a female patient who received Herpes zoster (Shingrix) (batch number NR55Z, expiry date 22nd October 2022) for prophylaxis. On 21st June 2021, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional details were provided as follows: The reporter stated that, patient was administered a first dose of shingrix that was left outside at room temperature for a week, which led to incorrect storage of drug. The reporter consented to follow up. The batch number of Shingrix was updated from NR55V to NR55Z as per sales data sheet.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1329649

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

gering
Staat
CA
Alter
51,0
Geschlecht
M
Eingang
19.05.2021
Impfdatum
11.05.2021
Beginn
11.05.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Product preparation error

Symptomtext

reconstituted by using sterile water; reconstituted by using sterile water; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 51-year-old male patient who received Herpes zoster (Shingrix) (batch number NR55Z, expiry date 22nd October 2022) for prophylaxis. On 11th May 2021, the patient received the 2nd dose of Shingrix. On 11th May 2021, unknown after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown. Additional details were provided as follows: The reporter was a medical assistant. The reporter stated that the patient received 2nd dose of Shingrix which was reconstituted by using sterile water, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1298800

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge NR55Z

gering
Staat
MO
Alter
79,0
Geschlecht
F
Eingang
08.05.2021
Impfdatum
28.04.2021
Beginn
28.04.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product preparation issue

Symptomtext

mistakenly mixed with sterile diluent rather than the provided additive; mistakenly mixed with sterile diluent rather than the provided additive / administered to a patient; This case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 79-year-old female patient who received Herpes zoster (Shingrix) (batch number NR55Z, expiry date 22nd October 2022) for prophylaxis. On 28th April 2021, the patient received the 1st dose of Shingrix. On 28th April 2021, unknown after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown. Additional details were provided as follows: The Shingrix was mistakenly mixed with sterile diluent rather than the provided additive, which led with wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter asked what steps should be taken from this point. The reporter confirmed that the dose was administered to a patient. The reporter consented to follow up via mail.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product preparation issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-